The available clinical data on the risk of neurodevelopmental disorders with levetiracetam is extremely limited and involves data on around 100 children (Shallcross et al 2011, Bech et al 2018, Huber-Mollema et al 2019 and 2020). Levetiracetam was also included in the meta-analysis by Veroniki et al (2017b). The available [...]